301-827-5814
robert.barry@nih.gov
Emphasis
The emphasis is on the development of MRI hardware and methodologies, including image acquisition and reconstruction techniques, that would improve the speed, spatial resolution, information content, efficiency, robustness, quality, patient experience, and safety. The emphasis should be on technological development rather than detailed applications to specific diseases or organs.
The program covers the development of new MRI techniques, methods and tools broadly, which include but are not limited to:
- fast MRI
- high and ultra-high field MRI
- pulse sequence and image reconstruction
- MRI of new contrast mechanisms
- design and implementation of novel magnets, gradients, radio-frequency coils, and other apparatus for in-scanner applications
- combination of MRI with other modalities with an emphasis on MRI hardware development
- in vivo MR Spectroscopy and spectroscopic imaging
- MRI of tissue properties, structure, metabolism, function and physiology
Related News
To date, nine medical device developers participating in the RADx® Tech Independent Test Assessment Program have received emergency use authorization for at-home and point-of care test products that simultaneously detect COVID-19 and flu A/B.
Scientists at the University of North Carolina at Chapel Hill have created innovative soft robots equipped with electronic skins and artificial muscles, allowing them to sense their surroundings and adapt their movements in real-time. These features make soft sensory robots highly adaptable and useful for enhancing medical diagnostics and treatments. Source: UNC Chapel Hill
Malignant primary brain tumors are the leading cause of cancer deaths among children and young adults with few therapeutic options. A preclinical study in Pharmaceutics shows that combining focused ultrasound with microbubbles opened the blood brain barrier to deliver immunotherapy into the brain of a large animal model.
NIBIB-supported researchers have developed a smart nanoprobe designed to infiltrate prostate tumors and send back a signal using an optical imaging technique known as Raman spectroscopy. The new probe, evaluated in mice, has the potential to determine tumor aggressiveness and could also enable sequential monitoring of tumors during therapy to quickly determine if a treatment strategy is working.
The absence of signs of brain injuries does not rule out the possibility of an external adverse event causing the symptoms, said Carlo Pierpaoli, the lead author on the neuroimaging paper.
Source: Washington Post